PD Dr. Benjamin Frey

Medizinische Fakultät Department of Radiation Oncology

Immune biological rationales for the design of combined radio- and immunotherapies (2020) Hader M, Frey B, Fietkau R, Hecht M, Gaipl U Journal article, Review article Peer review analysis in the field of radiation oncology: results from a web-based survey of the Young DEGRO working group (2020) Käsmann L, Schröder A, Frey B, Fleischmann DF, Gauer T, Ebert N, Hecht M, et al. Journal article Systemic modulation of stress and immune parameters in patients treated for prostate adenocarcinoma by intensity-modulated radiation therapy or stereotactic ablative body radiotherapy (2020) Frey B, Mika J, Jelonek K, Cruz-Garcia L, Roelants C, Testard I, Cherradi N, et al. Journal article Rare Loss-of-Function Mutation in SERPINA3 in Generalized Pustular Psoriasis (2020) Frey S, Sticht H, Wilsmann-Theis D, Gerschütz A, Wolf K, Löhr S, Haskamp S, et al. Journal article Analysis of the immune status from peripheral whole blood with a single-tube multicolor flow cytometry assay (2020) Donaubauer AJ, Becker I, Rühle PF, Fietkau R, Gaipl U, Frey B Book chapter / Article in edited volumes On PTV definition for glioblastoma based on fiber tracking of diffusion tensor imaging data (2020) Witulla B, Goerig N, Putz F, Frey B, Engelhorn T, Dörfler A, Uder M, et al. Journal article Single cycle induction treatment with cisplatin/docetaxel plus durvalumab/tremelimumab in stage III-IVB head and neck squamous cell cancer (CheckRad-CD8 trial) (2019) Hecht M, Gostian AO, Eckstein M, Rutzner S, Von Der Gruen J, Illmer T, Hautmann MG, et al. Conference contribution Rare frameshift mutation in SERPINA3 contributes to generalized pustular psoriasis (2019) Hüffmeier U, Sticht H, Wenzel J, Wilsmann-Theis D, Wolff K, Löhr S, Frey B, et al. Conference contribution Radiotherapy-induced changes in the systemic immune and inflammation parameters of head and neck cancer patients (2019) Balazs K, Kis E, Badie C, Bogdandi EN, Candeias S, Garcia LC, Dominczyk I, et al. Journal article Tumor Cell-Based Vaccine Generated With High Hydrostatic Pressure Synergizes With Radiotherapy by Generating a Favorable Anti-tumor Immune Microenvironment (2019) Seitz C, Ruckert M, Weiss EM, Utz S, Izydor M, Ebel N, Schlücker E, et al. Journal article, Original article